Funded Tech Companies
Entasis Therapeutics
Entasis Therapeutics, based in Waltham, received equity investments from Novo Ventures, Frazier Healthcare Partners and Clarus.
Company Overview
Company Name
Entasis Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
35 Gatehouse Dr.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Entasis Therapeutics (Nasdaq: ETTX) is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/25/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Manos Perros
Chief Medical Officer
David Altarac
Chief Scientific Officer
Ruben Tommasi
VP - Bus. Development
Michael Gutch
VP - Bus. Development
Eric Kimble
VP - Bus. Development
John Mueller
Company Investors
- Novo Ventures
- Frazier Healthcare Partners (James Topper)
- Clarus (Nicholas Galakatos)
- Eventide Asset Management
- AstraZeneca
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs